Citi Upgrades Ionis Pharmaceuticals (IONS) to Buy 'Considering Overall Pipeline Potential'
Tweet Send to a Friend
(Updated - July 31, 2023 4:02 AM EDT)
Citi analyst David Lebowitz upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst David Lebowitz upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
